Mycobacterium is a genus of bacteria best known for causing tuberculosis and leprosy, two of the oldest and most devastating infectious diseases in human history. The genus contains roughly 195 recognized species, most of which live harmlessly in soil and water. Only a handful are dangerous to humans, but the ones that are have shaped public health for centuries.
What makes mycobacteria distinctive isn’t the diseases they cause but the way they’re built. Their unusually thick, waxy cell wall sets them apart from nearly all other bacteria and explains why they’re so difficult to treat with standard antibiotics.
What Makes Mycobacteria Different From Other Bacteria
The defining feature of mycobacteria is their cell envelope, a multi-layered wall far thicker and more complex than what you’d find in typical bacteria. The outermost layer is packed with mycolic acids, long waxy molecules that form a dense, water-repelling barrier around the cell. This lipid-rich coating is essentially a fortress. It blocks many antibiotics from entering, shields the bacterium from the immune system’s chemical attacks, and makes mycobacteria remarkably tough survivors in harsh environments.
Beneath the mycolic acid layer sits a scaffold of sugars and peptidoglycan, a rigid mesh that gives the cell its shape and protects it from bursting. These layers are interconnected: the peptidoglycan links to a branching sugar chain called arabinogalactan, which in turn anchors the outer mycolic acid membrane. A loose capsule of sugars and proteins coats the whole structure. The result is a bacterium wrapped in so many protective layers that it resists not only antibiotics but also the acid and bleach-like chemicals your immune cells produce to kill invaders.
This waxy wall is also why mycobacteria are identified using a special laboratory stain called the acid-fast stain. In this technique, a red dye is applied to a sample, then an acid-alcohol wash strips the color from ordinary bacteria. Mycobacteria hold onto the red dye because their waxy coating prevents the acid from washing it out. Under the microscope, mycobacteria glow red against a blue background, a visual signature that has been used to diagnose tuberculosis for well over a century.
Slow Growers in a Fast World
Most bacteria can double their numbers in 20 to 30 minutes. Mycobacteria are extraordinarily slow by comparison. The tuberculosis bacterium, even under ideal laboratory conditions, takes about 16 hours to divide once. Some species are far slower, with doubling times stretching to 69 hours or more. This sluggish pace means that growing mycobacteria in a lab culture can take weeks rather than the overnight results typical for most bacterial infections.
Scientists historically split mycobacteria into two camps based on growth speed. Slow growers take seven days or more to form visible colonies on a culture plate. Fast growers appear in under seven days, though they’re still much slower than common bacteria like E. coli. An older classification system called the Runyon system further sorted slow growers by whether their colonies produced pigment in light (photochromogens), in the dark (scotochromogens), or not at all (nonchromogens). While modern genetic tools have largely replaced this system, the slow-versus-fast distinction still matters clinically because it influences which antibiotics work and how long treatment lasts.
The Major Disease-Causing Species
Three mycobacterial diseases dominate global health: tuberculosis, leprosy, and Buruli ulcer.
Tuberculosis is caused primarily by Mycobacterium tuberculosis, with related species like M. bovis (which also infects cattle) and M. africanum (common in parts of Africa) contributing a smaller share of cases. The World Health Organization has estimated that roughly one-third of the global population carries a latent tuberculosis infection, and about two million people die from the disease each year. TB typically attacks the lungs but can spread to the bones, kidneys, brain, and other organs.
Leprosy is caused by Mycobacterium leprae, a species so dependent on a human host that it still cannot be grown in a standard lab culture. More than 690,000 new cases are reported annually worldwide, concentrated in tropical regions. The bacterium damages peripheral nerves and skin, leading to numbness, disfigurement, and disability if untreated.
Buruli ulcer, caused by Mycobacterium ulcerans, is likely the third most common mycobacterial disease globally. It produces destructive skin ulcers, most frequently in West Africa, though outbreaks have occurred in Australia, the Americas, and Asia.
Non-Tuberculous Mycobacteria
The vast majority of mycobacterial species fall outside the tuberculosis and leprosy groups. These are collectively called non-tuberculous mycobacteria, or NTM. They live naturally in soil, dust, and especially water. NTM have been isolated from drinking water systems, hospital water supplies, dental aerosols, cooling towers, and even the filters used to clean medical equipment. They thrive across a wide range of temperatures, pH levels, and salt concentrations, which is why they turn up in so many environments.
In nature, NTM typically live in biofilms, the slimy communities of microorganisms that coat surfaces in contact with water. Inside these biofilms, mycobacteria interact with other bacteria and even single-celled organisms like amoebae. This lifestyle helps explain how they persist in treated water systems: the biofilm protects them from disinfectants that would kill free-floating bacteria.
NTM infections are not passed from person to person. People pick them up from environmental exposure, usually by inhaling contaminated water droplets or through breaks in the skin. The most commonly encountered group is the Mycobacterium avium complex, which can cause chronic lung infections, particularly in people with existing lung damage or weakened immune systems. Other notable NTM include M. kansasii, M. marinum (which causes skin infections from contaminated water, often fish tanks), and the M. abscessus complex, a fast-growing group notorious for infecting surgical wounds and causing difficult-to-treat lung disease.
How Mycobacteria Evade the Immune System
When most bacteria enter the body, immune cells called macrophages engulf and destroy them. Macrophages swallow the invader into a compartment called a phagosome, then fuse that compartment with a lysosome, a sac filled with digestive enzymes and acid. This normally dissolves the bacterium.
Mycobacterium tuberculosis has evolved to short-circuit this process. Once swallowed by a macrophage, the bacterium stalls the phagosome from maturing and blocks it from ever fusing with the lysosome. The macrophage, the very cell designed to kill intracellular invaders, becomes a safe house where the bacterium replicates. On top of this, mycobacteria neutralize the reactive oxygen and nitrogen molecules that macrophages produce as chemical weapons, and they maintain a stable internal pH even as the surrounding environment turns acidic. The thick, low-permeability cell wall adds yet another layer of defense, preventing many of these toxic molecules from reaching the bacterium’s interior in the first place.
Why Standard Antibiotics Often Fail
Mycobacteria are naturally resistant to many common antibiotics, including penicillin and related drugs. This isn’t resistance they’ve picked up from overuse of antibiotics. It’s built into their biology. Their lipid-heavy cell wall blocks water-soluble drugs from diffusing in. They produce an enzyme that breaks down penicillin-type antibiotics before they can act. They run molecular pumps that actively push antibiotics back out of the cell. And some of their drug targets are subtly different from those in other bacteria, so antibiotics designed for typical infections simply don’t bind well.
This intrinsic resistance is why treating mycobacterial infections requires specialized drug combinations taken for months or even years. Tuberculosis treatment, for example, typically involves a four-drug regimen taken for at least six months. NTM lung infections can require 12 to 18 months of therapy. The slow growth rate of the bacteria also complicates treatment, since most antibiotics work best against actively dividing cells.
Symptoms of Mycobacterial Infections
Lung infections are the most common form of mycobacterial disease, whether caused by TB or NTM. Symptoms tend to be vague and develop gradually: a persistent cough, shortness of breath, fatigue, weight loss, and general malaise. Because these overlap with many other conditions, mycobacterial lung infections are often diagnosed late, sometimes after months of symptoms.
Mycobacteria can also infect sites beyond the lungs. Skin and soft tissue infections produce painful nodules, plaques, or ulcers that may drain. Lymph node infections, especially in children, cause a painless but enlarging neck mass. Joint and bone infections bring pain, stiffness, fever, and weight loss. In people with severely weakened immune systems, mycobacteria can disseminate throughout the body, causing widespread rashes, enlarged lymph nodes, fever, and lesions in the liver and spleen.